Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Nepeta cataria (Nepetalactone).
Nepeta cataria functions primarily as a mild sedative and anxiolytic through the modulation of GABAergic signaling pathways, specifically via the interaction of its volatile iridoid nepetalactones with GABA-A receptors.
161500
295.19 g/mol
-3.6
[(2R,3S,4R,5R)-5-(5-aminoimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Nepeta cataria (Nepetalactone) across standard consumer modalities.
The high volatility of nepetalactone requires specialized hermetic sealing or oil-based softgels to prevent degradation and loss of potency over time.
Thermal processing during pectin gelation can lead to significant evaporation of the volatile active constituents, necessitating post-cool injection or encapsulation.
The hydrophobic nature and required therapeutic dosage of catnip extract often exceed the limited polymer matrix capacity of thin-film delivery systems.
Ready to launch a product featuring Nepeta cataria (Nepetalactone)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Nepeta cataria (Nepetalactone) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Nepeta cataria (Nepetalactone) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation